Microtransponder company information, Employees & Contact Information

Vivistim Co-Founder Named Innovator of the Year by the Congress of Neurological Surgeons PR Newswire

Connecticut Passes Law to Establish $2 Million Center of Excellence to Provide Veterans with Access to FDA-Approved Vivistim Therapy for Stroke Recovery PR Newswire

MicroTransponder nets $65M for stroke rehabilitation neurostimulator Fierce Biotech

MicroTransponder secures US$65 million financing round to boost adoption of Vivistim stroke therapy NeuroNews International

MicroTransponder Vivistim nerve stim tech delivers positive stroke outcomes MassDevice

Chronic Stroke Survivors Demonstrate Long-Term Improvement in Motor Impairment with Vivistim Therapy The AI Journal

MicroTransponder Secures $65 Million to Enhance Vivistim Adoption for Chronic Stroke Recovery PR Newswire

MicroTransponder has positive results for its stroke-recovery neurostim MassDevice

MicroTransponder highlights promising long-term data for VNS system Medical Device Network

MicroTransponder secures $65 million to expand stroke recovery therapy Medical Economics

MicroTransponder Medical Tech Outlook

MicroTransponder receives $65m to advance stroke care with Vivistim Medical Device Network

Stroke survivors achieve long-term improvement in motor function with VNS therapy NeuroNews International

Vivistim Paired VNS Therapy Outcomes & Success at Comprehensive Stroke Centers Highlighted at ISC 2025 PR Newswire

MicroTransponder raises $65M for nerve stim tech MassDevice

TIME Picks MicroTransponder's Vivistim Paired VNS System for 2023 Best Inventions List in Medical Care Category PR Newswire

MicroTransponder® Receives FDA Approval for Breakthrough Device Benefiting Stroke Survivors PR Newswire

MicroTransponder Wins Edison Award for The Vivistim Paired VNS System, A Game-Changer for Stroke Survivors PR Newswire

MicroTransponder Secures CMS Transitional Pass-Through Status & New Technology Add-On Payment for Its Breakthrough Stroke Rehabilitation System, Vivistim PR Newswire

First in Connecticut: Ischemic Stroke Survivors Have Renewed Hope with the Vagus Nerve Stimulation Device Now Available at UConn Health UConn Today

FDA approves ‘first of its kind’ vagus nerve stroke rehab technology McKnight's Long-Term Care News

Ischaemic stroke outcomes with Vivistim paired VNS therapy highlighted at ISC 2025 NeuroNews International

Targeted Vagus Nerve Stimulation for Rehabilitation After Stroke Frontiers

Vivistim Paired VNS System Awarded Gold Electrode Award for Best New Product by Neurotech Reports PR Newswire

MicroTransponder grabs macro funding round with $73M for stroke rehab neurostimulator Fierce Biotech

MicroTransponder: $65 Million (Series F) Raised For Enhancing Vivistim Adoption For Chronic Stroke Recovery Pulse 2.0

Occupational and Physical Therapists See Promise in New Paired VNS Therapy for Stroke Recovery PR Newswire

MicroTransponder gains FDA approval for first-of-its-kind VNS system to improve stroke rehabilitation NeuroNews International

First Commercial Vivistim Patient Set to Begin Paired VNS Therapy for Improved Upper Limb Function Post Stroke PR Newswire

MicroTransponder’s Vivistim Paired VNS System, USA Medical Device Network

MicroTransponder Vivistim Paired VNS System: The 200 Best Inventions of 2023 Time Magazine

Big news for Microtransponder with new CEO and $53M series E BioWorld MedTech

MicroTransponder receives best new product award for Vivistim system NeuroNews International

Texas-based stroke recovery tech company MicroTransponder raises $65M The Business Journals

First commercial Vivistim patient set to begin paired vagus nerve stimulation therapy NeuroNews International

FDA approves MicroTransponder’s stroke rehab neurostim system MassDevice

MicroTransponder Closes $73M in Series E Financing FinSMEs

Sagetech Avionics receives DOD AIMS certification for Mode 5 Micro IFF Transponder for UAVs Military Aerospace

MicroTransponder Raises $53M in Series E Funding FinSMEs